Share
Once fierce competitors, today Ginkgo Bioworks announced it's acquiring Zymergen. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View in Browser »

Hi ,

Once fierce competitors, today Ginkgo Bioworks announced it's acquiring Zymergen. Ginkgo plans to integrate Zymergen's core automation and software technologies for scaling strain engineering capacity into its Foundry, including Zymergen's machine learning and data science tools for exploring known and unknown genetic design space.

Ginkgo also announced it's going to acquire Bayer's 175,000-square-foot Biologics R&D center and enter into a new collaboration with Bayer to advance several agricultural biological programs. (Ginkgo will be at SynBioBeta 2023 at the Oakland Marriott, you can meet Jason Kelly and the rest of the team and purchase your early bird tickets today)

Jason Kelly, CEO of Ginkgo Bioworks, at SynBioBeta.

In case you missed it at SynBioBeta 2022, Julianna LeMieux, Science Writer at Genetic Engineering and Biotechnology News moderated a discussion with Gaurab Chakrabarti, CEO of Solugen, and Sean Hunt, CTO of Solugen (pictured below) about how Solugen is decarbonizing the chemicals industry. They use AI to engineer enzymes and metal catalysts that can bypass the limitations of traditional fermentation, allowing the team to produce molecules at room temperature using bio-based feedstocks, with no toxins and no waste.

In funding news this week, SynbiCITE, the UK’s National Centre for the Industrial Translation of Synthetic Biology, has received a £5.5M funding commitment from SynBioVen.

Paul Freemont, Co-Director of SynbiCITE, at SynBioBeta.

Finally, TetraScience announced a 5-year, $500 million investment in the ongoing development and delivery of a cloud-native, open, and purpose-built scientific data cloud as it lays the foundation for revolutionary AI- and ML-based discovery.

I hope you have a great week.

Regards,
John

---

John Cumbers
Founder, SynBioBeta

Featured News

Download the application note to learn how Inscripta’s Onyx® Digital Genome Engineering Platform can be used for rapid strain engineering to improve heterologous protein production.

Keep Reading »

Supercharged biotech rice yields 40% more grain

The change helps the plant absorb more fertilizer, boosts photosynthesis, and accelerates flowering, all of which could contribute to larger harvests.

Keep Reading »

Other News

Who's hiring?

Like our Digest? Please feel free to share with friends, family, and co-workers!


SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences


Email Marketing by ActiveCampaign